Literature DB >> 11030631

Endosonography and endoscopic magnetic resonance imaging.

S Nakazawa1, K Inui.   

Abstract

Endosonography is an important modality for the diagnosis and staging of oesophageal, gastric, colorectal and pancreatobiliary malignancy. It is also recognized as a reliable method for the evaluation of submucosal tumours of the gastrointestinal tract, for differentiating benign lesions from giant gastric folds, and for the localization of pancreatic endocrine tumours. The latest development, that of endosonographic fine-needle aspiration, provides for the cytological diagnosis of gastrointestinal tumours. This new technique may also be used for endoscopic therapy. High-frequency probes can be used to make a more accurate diagnosis of superficial carcinoma of the gastrointestinal tract, for three-dimensional imaging of gastrointestinal tumours and for intraductal ultrasonography of the bile duct and pancreatic duct. Endoscopic magnetic resonance imaging provides information not obtainable with endosonography or other modalities. It has high potential in the diagnosis and staging of gastrointestinal and pancreatobiliary tumours.

Entities:  

Mesh:

Year:  1999        PMID: 11030631     DOI: 10.1053/bega.1999.0005

Source DB:  PubMed          Journal:  Baillieres Best Pract Res Clin Gastroenterol


  3 in total

1.  High-resolution MR imaging appearance of colonic tissue in rabbits using an endoluminal coil.

Authors:  Frank Pilleul; Olivier Beuf; Claire Godefroy; Jean-Yves Scoazec; Mircea Armenean; Cristina Armenean; Emmanuel Perrin; Pierre-Jean Valette; Hervé Saint Jalmes
Journal:  MAGMA       Date:  2005-11-18       Impact factor: 2.310

Review 2.  Nonsurgical approaches to esophageal malignancy.

Authors:  Darius Sorbi; David E Fleischer
Journal:  Curr Gastroenterol Rep       Date:  2003-06

Review 3.  Diagnostic procedures for submucosal tumors in the gastrointestinal tract.

Authors:  Laura-Graves Ponsaing; Katalin Kiss; Annika Loft; Lise-Ingemann Jensen; Mark-Berner Hansen
Journal:  World J Gastroenterol       Date:  2007-06-28       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.